Merit Medical Systems Total Liabilities 2010-2023 | MMSI
Merit Medical Systems total liabilities from 2010 to 2023. Total liabilities can be defined as the total value of all possible claims against the corporation.
Merit Medical Systems Annual Total Liabilities
(Millions of US $) |
| 2023 |
$1,123 |
| 2022 |
$520 |
| 2021 |
$608 |
| 2020 |
$706 |
| 2019 |
$807 |
| 2018 |
$687 |
| 2017 |
$435 |
| 2016 |
$445 |
| 2015 |
$313 |
| 2014 |
$312 |
| 2013 |
$323 |
| 2012 |
$324 |
| 2011 |
$90 |
| 2010 |
$134 |
| 2009 |
$53 |
Merit Medical Systems Quarterly Total Liabilities
(Millions of US $) |
| 2023-12-31 |
$1,123 |
| 2023-09-30 |
$579 |
| 2023-06-30 |
$634 |
| 2023-03-31 |
$512 |
| 2022-12-31 |
$520 |
| 2022-09-30 |
$544 |
| 2022-06-30 |
$558 |
| 2022-03-31 |
$573 |
| 2021-12-31 |
$608 |
| 2021-09-30 |
$630 |
| 2021-06-30 |
$650 |
| 2021-03-31 |
$675 |
| 2020-12-31 |
$706 |
| 2020-09-30 |
$737 |
| 2020-06-30 |
$787 |
| 2020-03-31 |
$809 |
| 2019-12-31 |
$807 |
| 2019-09-30 |
$812 |
| 2019-06-30 |
$786 |
| 2019-03-31 |
$750 |
| 2018-12-31 |
$687 |
| 2018-09-30 |
$387 |
| 2018-06-30 |
$592 |
| 2018-03-31 |
$551 |
| 2017-12-31 |
$435 |
| 2017-09-30 |
$420 |
| 2017-06-30 |
$385 |
| 2017-03-31 |
$363 |
| 2016-12-31 |
$445 |
| 2016-09-30 |
$443 |
| 2016-06-30 |
$335 |
| 2016-03-31 |
$331 |
| 2015-12-31 |
$313 |
| 2015-09-30 |
$309 |
| 2015-06-30 |
$302 |
| 2015-03-31 |
$297 |
| 2014-12-31 |
$312 |
| 2014-09-30 |
$322 |
| 2014-06-30 |
$328 |
| 2014-03-31 |
$332 |
| 2013-12-31 |
$323 |
| 2013-09-30 |
$323 |
| 2013-06-30 |
$339 |
| 2013-03-31 |
$329 |
| 2012-12-31 |
$324 |
| 2012-09-30 |
$138 |
| 2012-06-30 |
$130 |
| 2012-03-31 |
$126 |
| 2011-12-31 |
$90 |
| 2011-09-30 |
$68 |
| 2011-06-30 |
$112 |
| 2011-03-31 |
$134 |
| 2010-12-31 |
$134 |
| 2010-09-30 |
$134 |
| 2010-06-30 |
$50 |
| 2010-03-31 |
$53 |
| 2009-12-31 |
$53 |
| 2009-09-30 |
$53 |
| 2009-06-30 |
$53 |
| 2009-03-31 |
$43 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$4.261B |
$1.257B |
|
Merit Medical Systems, Inc. provides various peripheral and cardiac intervention products to cure cardiac conditions specific to interventional cardiology and electrophysiology. The company offers products focused in five core product groups: peripheral intervention, cardiac intervention, interventional oncology and spine, cardiovascular and critical care as well as endoscopy. However, the company operates in two revenue segments: Cardiovascular and Endoscopy Devices.
|
